IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Drug, Healthcare and Patient Safety

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

3.46

h-Index

2024-2025

 32

Rank

2024-2025

 7825

SJR

2024-2025

 0.72

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Drug, Healthcare and Patient Safety
Abbreviation Drug Healthc. Patient Saf.
Publication Type Journal
Subject Area, Categories, Scope Health Policy (Q2); Pharmacology (Q2)
h-index 32
Overall Rank/Ranking 7825
SCImago Journal Rank (SJR) 0.72
Impact Score 3.46
Publisher Dove Medical Press Ltd
Country New Zealand
ISSN 11791365
Best Quartile Q2
Coverage History 2009-2025




About Drug, Healthcare and Patient Safety


Drug, Healthcare and Patient Safety is a journal covering the technologies/fields/categories related to Health Policy (Q2); Pharmacology (Q2). It is published by Dove Medical Press Ltd. The overall rank of Drug, Healthcare and Patient Safety is 7825. According to SCImago Journal Rank (SJR), this journal is ranked 0.72. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 32. The best quartile for this journal is Q2.

The ISSN of Drug, Healthcare and Patient Safety journal is 11791365. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug, Healthcare and Patient Safety is cited by a total of 205 articles during the last 3 years (Preceding 2024).


Drug, Healthcare and Patient Safety Impact IF 2024-2025


The Impact IF 2024 of Drug, Healthcare and Patient Safety is 3.46, which is computed in 2025 as per its definition. Drug, Healthcare and Patient Safety IF is increased by a factor of 0.94 and approximate percentage change is 37.3% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Drug, Healthcare and Patient Safety Impact IF 2025 Prediction


Impact IF 2024 of Drug, Healthcare and Patient Safety is 3.46. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Drug, Healthcare and Patient Safety. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 3.46
2023 2.52
2022 1.70
2021 1.36
2020 1.46
2019 1.91
2018 1.67
2017 1.07
2016 1.95
2015 1.73
2014 1.60

Drug, Healthcare and Patient Safety h-index


  Table Setting

Drug, Healthcare and Patient Safety has an h-index of 32. It means 32 articles of this journal have more than 32 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Drug, Healthcare and Patient Safety ISSN


The ISSN of Drug, Healthcare and Patient Safety is 11791365. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Drug, Healthcare and Patient Safety Rank and SCImago Journal Rank (SJR)


The overall rank of Drug, Healthcare and Patient Safety is 7825. According to SCImago Journal Rank (SJR), this journal is ranked 0.72. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Drug, Healthcare and Patient Safety by Year


Year SJR
2025/2026 Coming Soon
2024 0.72
2023 0.571
2022 0.311
2021 0.355
2020 0.530
2019 0.473
2018 0.343
2017 0.481
2016 0.531
2015 0.531
2014 0.733

Ranking of Drug, Healthcare and Patient Safety by Year


Year Ranking
2025/2026 Coming Soon
2024 7825
2023 9448
2022 14805
2021 13177
2020 9523
2019 10285
2018 12597
2017 9505
2016 8805
2015 8741
2014 6332

Drug, Healthcare and Patient Safety Publisher


Table Setting

Drug, Healthcare and Patient Safety is published by Dove Medical Press Ltd. It's publishing house is located in New Zealand. Coverage history of this journal is as following: 2009-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Drug, Healthcare and Patient Safety is Drug Healthc. Patient Saf.. This abbreviation ('Drug Healthc. Patient Saf.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Drug, Healthcare and Patient Safety


If your research field is/are related to Health Policy (Q2); Pharmacology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Drug, Healthcare and Patient Safety?

Drug, Healthcare and Patient Safety latest impact IF is 3.46. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.46 (2024) and 1.07 (2017), respectively, in the last 11 years. Moreover, its average IS is 1.86 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Drug, Healthcare and Patient Safety?

The Drug, Healthcare and Patient Safety has an SJR (SCImago Journal Rank) of 0.72, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.733 in 2014 and the lowest being 0.311 in 2022. Furthermore, the average SJR of the Drug, Healthcare and Patient Safety over the previous 11-year period stands at 1.86.


What's the latest h-index of the Drug, Healthcare and Patient Safety?

The latest h-index of the Drug, Healthcare and Patient Safety is 32.


Who's the publisher of the Drug, Healthcare and Patient Safety?

The Drug, Healthcare and Patient Safety is published by the Dove Medical Press Ltd, with its country of publication being the New Zealand.


What's the current ranking of the Drug, Healthcare and Patient Safety?

The Drug, Healthcare and Patient Safety is currently ranked 7825 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 6332 in 2014 and its lowest position of 14805 in 2022.


What's the abbreviation or short name for the Drug, Healthcare and Patient Safety?

The standard ISO4 abbreviation for the Drug, Healthcare and Patient Safety is Drug Healthc. Patient Saf..


Is the "Drug, Healthcare and Patient Safety" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Drug, Healthcare and Patient Safety is classified as a journal that the Dove Medical Press Ltd publishes.


What's the scope or major areas of the Drug, Healthcare and Patient Safety?

The Drug, Healthcare and Patient Safety encompasses the following areas:

  • Health Policy
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Drug, Healthcare and Patient Safety?

The Drug, Healthcare and Patient Safety is assigned the following International Standard Serial Numbers (ISSN): 11791365.


What's the best quartile of the Drug, Healthcare and Patient Safety?

The best quartile for the Drug, Healthcare and Patient Safety is Q2 (2024).


What's the coverage history of the Drug, Healthcare and Patient Safety?

The Drug, Healthcare and Patient Safety coverage history can be summarized as follows: 2009-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Academic Ethics journal 8704 Springer Netherlands 34 4.04
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
International Journal of Applied Linguistics journal 6655 Wiley-Blackwell Publishing Ltd 57 2.61
Canadian Journal of Education journal 15557 Canadian Society for the Study of Education (CSSE) 46 0.80
Socialism and Democracy journal 27160 Taylor and Francis Ltd. 19 0.20
Howard Journal of Communications journal 14582 Taylor and Francis Ltd. 42 1.27
Palaeontographica Abteilung B: Palaeophytologie book series 10600 Schweizerbart Science Publishers 18 4.25
European Surgery - Acta Chirurgica Austriaca journal 18136 Springer Medizin 25 0.68
Canadian Journal of Mathematics journal 7806 Canadian Mathematical Society 48 0.98
Consulting engineer Barrington journal 24079 Cahners Pub. Co. 0 0.00

Check complete list




Year wise Impact Score (IS) of Drug, Healthcare and Patient Safety

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 3.46
2023 2.52
2022 1.70
2021 1.36
2020 1.46
2019 1.91
2018 1.67
2017 1.07
2016 1.95
2015 1.73
2014 1.60



Top Journals/Conferences in Health Policy

Lancet Planetary Health, The
Elsevier B.V. | Netherlands

Implementation Science
BioMed Central Ltd | United Kingdom

Health Affairs
Project HOPE | United States

Lancet Regional Health - Europe, The
Elsevier Ltd | United Kingdom

Alzheimer's and Dementia
John Wiley and Sons Inc | United States

International Journal of Transgender Health
Routledge | United Kingdom

Milbank Quarterly
Wiley-Blackwell Publishing Ltd | United Kingdom

Lancet Regional Health - Americas, The
Elsevier Ltd | United Kingdom

JAMA Health Forum
American Medical Association | United States

Lancet Regional Health - Western Pacific, The
Elsevier Ltd | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All